Asper Biogene OÜRegistered
Key figures
589 232 €−9,3%
Revenue 2025
−2,4%
Average annual change 2019–2025
Ratios
2025−28,5%
Profit margin
6,6%
EBITDA margin
49,6%
Equity ratio
1,3×
Current ratio
−149,0%
Return on equity
1222 €
Average gross salary
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q2 2026 | 62 570 € | 11 | 19 577 € |
| Q1 2026 | 61 730 € | 11 | 28 024 € |
| Q4 2025 | 53 643 € | 12 | 25 565 € |
| Q3 2025 | 62 090 € | 13 | 24 010 € |
| Q2 2025 | 72 390 € | 13 | 24 406 € |
| Q1 2025 | 50 100 € | 13 | 23 024 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Summary of financial statements2019–2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||
| Total current assets | 154 865 | 134 445 | 118 675 | 234 590 | 196 090 | 121 827 | 121 222 |
| Total non-current assets | 168 952 | 218 662 | 303 812 | 360 098 | 295 524 | 270 129 | 105 781 |
| Total assets | 323 817 | 353 107 | 422 487 | 594 688 | 491 614 | 391 956 | 227 003 |
| Balance sheet — liabilities and equity | |||||||
| Current liabilities | 133 344 | 169 198 | 203 113 | 241 220 | 123 518 | 90 228 | 95 078 |
| Non-current liabilities | 90 200 | 42 995 | 42 995 | 21 278 | 21 278 | 21 278 | 19 278 |
| Total liabilities | 223 544 | 212 193 | 246 108 | 262 498 | 144 796 | 111 506 | 114 356 |
| Share capital | 2500 | 2500 | 2500 | 2500 | 2500 | 2500 | 2500 |
| Retained earnings of previous periods | 83 723 | 97 523 | 138 164 | 173 629 | 329 440 | 344 068 | 277 700 |
| Profit for the year | 14 050 | 40 641 | 35 465 | 155 811 | 14 628 | −66 368 | −167 803 |
| Reserves and other equity | — | 250 | 250 | 250 | 250 | 250 | 250 |
| Total equity | 100 273 | 140 914 | 176 379 | 332 190 | 346 818 | 280 450 | 112 647 |
| Income statement | |||||||
| Sales revenue | 681 879 | 786 521 | 651 969 | 782 438 | 825 111 | 649 888 | 589 232 |
| Operating profit | 12 805 | 56 924 | 43 345 | 188 080 | 20 191 | −62 756 | −162 968 |
| EBITDA | 26 761 | 80 947 | 67 368 | 236 032 | 242 367 | 38 452 | 38 990 |
| Profit before income tax | 14 050 | 40 641 | 35 465 | 155 811 | 14 628 | −66 368 | −167 803 |
| Profit for the reporting year | 14 050 | 40 641 | 35 465 | 155 811 | 14 628 | −66 368 | −167 803 |
| Labour costs | 334 403 | 316 976 | 247 248 | 181 994 | 172 530 | 212 485 | 223 000 |
| Depreciation of non-current assets | 13 956 | 24 023 | 24 023 | 47 952 | 222 176 | 101 208 | 201 958 |
| Other indicators | |||||||
| Employees | 14 | 13 | 11 | 9 | 9 | 9 | 9 |
| Calculated dividend | — | 0 | 0 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
CompanyPersonShareholderOther roleAdditional link
Annual reportsPDF, XBRL
Loading list of reports…
Source: e-Business Register (RIK). Files open/download directly from the official register.
Related companies
Same activity — Research and development in natural sciences and engineering